ImmunoMet Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $842K (Form D filed Feb 5, 2026). SEC Form D 0002109829-26-000001 (Feb 5, 2026)
  Evidence (1 event)

  • Feb 5, 2026 · SEC Form D 0002109829-26-000001
    Name of Issuer: Immunomet Therapeutics, Inc.; CIK: 2109829; Address: Houston, TX; Submission type: D; Filing date: 2026-02-05; Industry Group: Biotechnology; Date of First Sale: 2026-01-21; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 842211; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals